DoIT MOEA AI-Enhanced Vaccines and Anti-Pulmonary Inflammatory Drugs Shine at BIO Asia-Taiwan 2025: Health Maintenance, Prevention, and Treatment-A Triple Strategy for a Resilient and Healthy Taiwan

Premier Cho pledges further biotechnology development

Taiwan starups make waves at BIO International Convention

Taiwan promotes biotechnology industry development

MOEA, ASOA stage biotechnology medical industry event

Super-aged Precision Regenerative Medicine Project unveils midterm results

Targeting rhythm control of tremor disorders—from the core mechanism to treatment opportunity

Taiwan attends BIO International Convention in California

Sulfated Disaccharide Reduces Neuronal Degeneration. A New Approach to Treating Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

President Tsai meets delegation from US-based National Resilience

Watching the DNA repair process by a photolyase at atomic resolution

NHRI researchers find DUSP8 is a key to the induction of asthma and atopic dermatitis

Taipei Entrepreneurs Hub (TEH) Announces the Winning Teams for the ‘Win A Greater Health’ International Online Pitch Contest!

A New Light in Brain Injury Treatment: Drug Repositioning Targets Neuroregeneration

MOEA Showcases New Prostate Cancer Drug and Simulated Plant-Based Meat

Novel Treatment Strategy for Helicobacter pylori Infection - Taiwan research team’s outstanding findings of molecular testing guided precision treatment for Helicobacter pylori infection have been published as a cover story in the Lancet Gastroenterology and Hepatology

Precise Delivery of Magnetically Modified Viruses –A New Opportunity for Virotherapy

Academia Sinica and Moderna sign agreement to promote mRNA technology development

MOEA Announced Global First Dual-Function Anti-Cancer ADC Drug, to Build an ADC Drug Development and Manufacturing Base through DCB’s Collaborating with Industry

Taiwan academia once again broke the world record of organic near-infrared intense emission